https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-15 / Cancer 2009 Jan;115(2):311-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-15 / Cancer 2009 Jan;115(2):311-232009-01-15 00:00:002019-02-15 09:17:38Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Electromagn Biol Med 2009;28(2):148-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Electromagn Biol Med 2009;28(2):148-652009-01-01 00:00:002019-02-15 09:17:31Oncothermia treatment of cancer: from the laboratory to clinic
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-4022008-12-17 00:00:002019-02-15 09:17:37The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-82008-12-06 00:00:002008-12-06 00:00:00Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-622008-12-01 00:00:002019-02-15 09:17:39Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-27 / Surg. Today 2008;38(10):911-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-27 / Surg. Today 2008;38(10):911-202008-09-27 00:00:002008-09-27 00:00:00Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-4082008-08-01 00:00:002008-08-01 00:00:00Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / J Biomech Eng 2008 Aug;130(4):041016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / J Biomech Eng 2008 Aug;130(4):0410162008-08-01 00:00:002019-02-15 10:00:35A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-712008-07-11 00:00:002008-07-11 00:00:00TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-01 / Curr Opin Oncol 2008 Jul;20(4):438-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-01 / Curr Opin Oncol 2008 Jul;20(4):438-432008-07-01 00:00:002008-07-01 00:00:00Regional hyperthermia in high-risk soft tissue sarcomas
